Shuying Ai
发表
miR‑378a enhances the sensitivity of liver cancer to sorafenib by targeting VEGFR, PDGFRβ and c‑Raf.
Li Tang,
Fengqin Wang,
Jicai Zhang,
2018,
Molecular medicine reports.